SI-BONE, Inc. SIBN
Nov 4, 2026, 9:46 AM EST
- YTD
- +26.14%
- 1 year
- +62.05%
- Market cap
- 1.10B
- Revenue (ttm)
- 213.60M
- Profit margin
- -6.85%
- EPS (ttm)
- -0.31
- Shares out
- 44.82M
- Forward P/E
- -76.66
- YTD return
- +26.14%
- 1-year return
- +62.05%
- Volume
- 132.76K
- Avg volume
- 620.29K
- Open
- 24.00
- Previous close
- 23.77
- Day's range
- 23.88 – 25.00
- 52-week range
- 11.48 – 25.00
- Beta
- 0.62
- Analysts
- Strong Buy
- Price target
- 25.89 (+4.1%)
- Earnings date
- Feb 22, 2027
5m +2.14 (+9.89%)
Key statistics
- Enterprise value
- 803.09M
- PEG ratio
- 0.00
- Price / sales
- 4.99
- Price / book
- 5.84
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 15.20%
- Free cash flow
- -861.88K
- Total cash
- 145.94M
- Total debt
- 42.80M
- Return on equity
- -8.30%
- Short % of float
- 12.23%
- 50-day average
- 19.42
- 200-day average
- 16.41
Analyst view
Consensus: strong buy
- Target (low)
- 20.00
- Target (mean)
- 25.89
- Target (high)
- 32.00
- Strong buy3
- Buy6
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 22, 2027
Expected Feb 22, 2027. Consensus EPS estimate -0.12813.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 22, 2027 | Dec 30, 2026 | -0.11 | — | — | — |
| Nov 2, 2026 | Sep 30, 2026 | -0.12637 | -0.08 | +0.05 | +36.69% |
| Aug 3, 2026 | Jun 30, 2026 | -0.14946 | -0.09 | +0.06 | +39.78% |
| May 11, 2026 | Mar 31, 2026 | -0.17 | -0.10 | +0.07 | +41.18% |
| Feb 23, 2026 | Dec 31, 2025 | -0.13 | -0.04 | +0.09 | +69.23% |
| Nov 10, 2025 | Sep 30, 2025 | -0.16 | -0.11 | +0.05 | +31.25% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | UBS | main | Buy | Buy |
| Nov 3, 2026 | TD Cowen | main | Buy | Buy |
| Nov 3, 2026 | Needham | main | Buy | Buy |
| Oct 14, 2026 | Truist Securities | main | Buy | Buy |
| Aug 4, 2026 | UBS | main | Buy | Buy |
| Aug 4, 2026 | Truist Securities | reit | Buy | Buy |
About SI-BONE, Inc.
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- si-bone.com
News
TD Cowen Maintains Buy on SI-BONE, Raises Price Target to $23
Needham Maintains Buy on SI-BONE, Lowers Price Target to $26
SI-BONE, Inc. (SIBN) Q3 2026 Earnings Call Transcript
SiBone Q3 Earnings Call Highlights
Si-Bone (SIBN) Reports Q3 Loss, Tops Revenue Estimates
SI-BONE Q3 2026 Earnings Call Transcript SI-BONE Affirms FY2026 Sales Guidance of $231.000M-$233.000M vs $232.024M Est
SI-BONE Q3 EPS $(0.08) Beats $(0.13) Estimate, Sales $55.704M Beat $55.404M Estimate
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue Guidance
SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026
Your note
Sign in to keep a note on SIBN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DAVIS TIMOTHY E JR | Director | Stock Award(Grant) | Jun 3, 2026 | 76,679 |
| DUNN JEFFREY W | Director | Sale | Sep 30, 2026 | 97,130 |
| FRANCIS LAURA A. | Chief Executive Officer | Sale | Oct 11, 2026 | 0 |
| FREUND JOHN GORDON | Director | Stock Award(Grant) | Jun 3, 2026 | 146,025 |
| HILLEMAN JERYL L | Director | Stock Award(Grant) | Jun 3, 2026 | 43,772 |
| HINCKLEY GREGORY K | Director | Conversion of Exercise of derivative security | Apr 6, 2026 | 180,738 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| First Light Asset Management, LLC | 18.33% | 8,127,985 | 193.20M | Jun 29, 2026 |
| Blackrock Inc. | 8.29% | 3,676,259 | 87.38M | Jun 29, 2026 |
| Cadian Capital Management, LP | 7.55% | 3,347,574 | 79.57M | Jun 29, 2026 |
| American Century Companies Inc | 5.66% | 2,510,963 | 59.69M | Jun 29, 2026 |
| Brown Advisory Inc. | 4.68% | 2,077,134 | 49.37M | Jun 29, 2026 |
| Granahan Investment Management LLC | 4.35% | 1,931,182 | 45.90M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 4.28% | 1,895,954 | 45.07M | Jul 30, 2026 |
| IMPAX FUNDS SERIES TRUST I-Impax Small Cap Fund | 3.21% | 1,425,010 | 33.87M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.01% | 1,337,048 | 31.78M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.56% | 1,136,594 | 27.02M | Sep 29, 2026 |
| First Eagle Funds-First Eagle Small Cap Opportunity Fund | 1.52% | 673,476 | 16.01M | Jul 30, 2026 |
| College Retirement Equities Fd.-College Retirement Equities Fd. - Tota | 1.30% | 578,354 | 13.75M | Jun 29, 2026 |
